Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL715643 | 0.80 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1CA1CA2MMP1 | |
| SCHEMBL12963983 | 0.78 | CA2 (0.36) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL14255394 | 0.78 | ALDH1A1 (0.35) | ALDH1A1L3MBTL1CA1CA2MMP1 | |
| Water SCHEMBL10964102 | 0.77 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1CA1CA2MMP1 | |
| SCHEMBL3751488 | 0.77 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1CA1CA2MMP1 | |
| Fluoride SCHEMBL3208832 | 0.77 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1CA1CA2MMP1 | |
| SCHEMBL2499165 | 0.77 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1CA1CA2MMP1 | |
| SCHEMBL3743473 | 0.77 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1CA1CA2MMP1 | |
| SCHEMBL5014768 | 0.77 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1CA1CA2MMP1 | |
| SCHEMBL11889340 | 0.77 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1CA1CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200115382-A1 | CURABLE COMPOSITION, CURED FILM, OPTICAL FILTER, SOLID IMAGE PICKUP ELEMENT, IMAGE DISPLAY DEVICE, INFRARED SENSOR, DISPERSING AUXILIARY AGENT, DISPERSION, AND METHOD OF MANUFACTURING DISPERSION | FUJIFILM CORPORATION (JP) | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115382-A1 | CURABLE COMPOSITION, CURED FILM, OPTICAL FILTER, SOLID IMAGE PICKUP ELEMENT, IMAGE DISPLAY DEVICE, INFRARED SENSOR, DISPERSING AUXILIARY AGENT, DISPERSION, AND METHOD OF MANUFACTURING DISPERSION | PRKG2, PRKD1, PRKG1 | ALDH1A1 2778/4885L3MBTL1 3046/4885CA1 371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.